BCAL Diagnostics Limited (AU:BDX) has released an update.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
BCAL Diagnostics Limited is set to issue 12 million unlisted options as part of an employee incentive scheme. This move indicates the company’s strategic focus on retaining and motivating its workforce as it continues to grow. Investors may find this development promising for the company’s long-term potential.
For further insights into AU:BDX stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue